Dalteparin and blood alkaline phosphatase increased Patient Reports February 12, 2012

Dalteparin Side Effects Report #5872551-4
Dalteparin side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 22, 2008. Male patient, 79 years of age, was diagnosed with thrombosis prophylaxis and was treated with Dalteparin. After drug was administered, patient experienced the following side effects: blood albumin decreased, blood alkaline phosphatase increased, blood creatinine increased, blood phosphorus decreased, blood sodium decreased, gamma-glutamyltransferase increased, haemoglobin decreased, hypotension, international normalised ratio increased. Dalteparin dosage: unknown. Patient died on 08/22/2008.

Dalteparin Side Effects Report #5902582-7
Dalteparin side effect was reported by a Health Professional from UNITED KINGDOM on Sept 09, 2008. Male patient, 79 years of age, was diagnosed with thrombosis prophylaxis and was treated with Dalteparin. After drug was administered, patient experienced the following side effects: blood albumin decreased, blood alkaline phosphatase increased, blood creatinine increased, blood phosphorus abnormal, blood sodium decreased, gamma-glutamyltransferase increased, hypotension, platelet count decreased, pneumonia . Dalteparin dosage: unknown. During the same period patient was treated with CODEINE PHOSPHATE AND ACETAMINOPHEN, IBUPROFEN, GABAPENTIN, OMEPRAZOLE, TRAZODONE, AMLODIPINE, DISOPYRAMIDE, RAMIPRIL. Patient died on 08/22/2008.

Dalteparin Side Effects Report #5055920-4
Dalteparin side effect was reported by a Pharmacist from UNITED STATES on July 17, 2006. Male patient, 25 years of age, was diagnosed with thrombosis prophylaxis and was treated with Dalteparin. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood alkaline phosphatase increased, blood bilirubin increased, platelet count decreased. Dalteparin dosage: unknown. During the same period patient was treated with FONDAPARINUX. Patient recovered.